New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation Today, physicians may utilize a separate mapping ...
MARLBOROUGH, Mass. and SAN DIEGO, April 24, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of the ...
The pulsed-field ablation (PFA) market is fierce. However, Boston Scientific hopes to gain an advantage with the new Farawave Nav Ablation Catheter. The Marlborough, MA-based company announced it won ...
Boston Scientific Corp. recently received CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview mapping software to be used with its Farapulse pulsed field ablation (PFA) ...
Add Yahoo as a preferred source to see more of our stories on Google. Boston Scientific’s acquisition of Intera Oncology is expected to close in the first half of 2025. Image credit: Michael Vi / ...
US physicians now have access to a second pulsed-field ablation (PFA) option to treat their patients with atrial fibrillation (AF) following the US Food and Drug Administration’s approval of the ...
MARLBOROUGH, Mass., April 8, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the NAVIGATE-PF study of the FARAVIEW™ Software Module* when it is used to visualize and track ...
Boston Scientific has received US Food and Drug Administration (FDA) approval for the Farapulse Pulsed Field Ablation (PFA) system for the isolation of pulmonary veins in the treatment of ...
Positive data for FARAPULSE™ Pulsed Field Ablation and WATCHMAN™ LAAC Devices underscore therapy safety and effectiveness in late-breaking clinical trial sessions MARLBOROUGH, Mass. and CHICAGO, April ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results